Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC Zovirax

This article was originally published in The Tan Sheet

Executive Summary

Has been available in Germany for the treatment of cold sores since July 1992 under a marketing agreement between Burroughs Wellcome and Hoechst ("The Tan Sheet" March 8, p. 8). The 5% acyclovir OTC dose in Germany is the same topical dose available as a prescription in the U.S. Zovirax is also marketed over-the- counter in New Zealand, Finland and South Africa, and has been approved for OTC use in Denmark, where it has not yet been launched.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS081228

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel